Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Leukemia - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

  • Studying Immune System Reconstitution Following Unrelated Donor Transplantation and Graft-Versus-Host-Disease Prevention
    (Posted: 01/13/2009) - Patients with high-risk, advanced hematologic malignancies will undergo induction chemotherapy, reduced-intensity immune-depleting chemotherapy, and allogeneic stem cell transplantation from a matched, unrelated donor, followed by graft-versus-host disease prevention.
  • Preventing Respiratory Infections in Patients with CLL
    (Posted: 10/21/2008) - This Featured Clinical Trial is a randomized, double-blind, placebo-controlled study to test the ability of CVT-E002 (COLD-fx) to reduce acute respiratory infections and the need for antibiotic treatment during the peak respiratory illness season (January through March) in people with chronic lymphocytic leukemia.
  • Inhibiting Tumor Angiogenesis in Children
    (Posted: 01/22/2008) - In this trial, researchers are testing an angiogenesis inhibitor called cediranib in pediatric patients who have solid tumors (except brain tumors) or acute myeloid leukemia (AML), a type of blood cancer.
  • Targeted Therapy for Lymphoid Cancers
    (Posted: 05/29/2007) - Patients with T-cell or B-cell lymphoid cancers that have recurred or progressed despite prior chemotherapy will receive the drug ABT-263 orally for up to a year in this phase I/II clinical trial.
  • Monoclonal Antibody Therapy for Treatment-Resistant Blood Cancers
    (Posted: 03/29/2005, Updated: 05/16/2007) - This phase I dose-escalation study is investigating safety and tolerability of siplizumab, and will determine the maximum dose that can be given to patients with CD2-positive lymphoproliferative disease.
< Previous  1 2 3 4  Next >